Autism There is increasing evidence that glutathione levels in autistic individuals are lower, which could be due to the increase in oxidative damage and inflammation
Comparing Herbal Tea Benefits to Clinical GLP-1 Therapy Herbal beverages like yerba mate may boost energy and provide antioxidants, but their impact on weight loss is modest and inconsistent across studies
M., Birtcher K
Book Consultation How Semaglutide Works Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the incretin hormone your small intestine produces after eating
%3F)
Insurance Coverage Predictions CagriSema (Advantage: Semaglutide Component): Leverages Wegovy's established coverage "Combination of proven medication + new molecule" easier sell to insurers Predicted coverage: 50-60% of commercial plans initially Retatrutide (Challenge: Novel Molecule): Entirely new drug class, no established coverage Higher efficacy but also higher side effects Will likely require trial-and-failure of cheaper options Predicted coverage: 40-50% of commercial plans initially Clinical Trial Populations and Indications CagriSema: Diabetes Focus REDEFINE-1: Obesity without diabetes (3,417 participants) REDEFINE-2: Obesity WITH type 2 diabetes (1,206 participants) REIMAGINE Program: Additional diabetes-focused trials Advantage: Strong diabetes data positions CagriSema for dual obesity + diabetes indications, like tirzepatide (Mounjaro/Zepbound)
As our understanding of this process grows, so does the interest in interventions like peptide therapy
